Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  vinblastine sulfate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 486 for your search:
Start Over
Phase II/III Randomized Study of EM/VBL vs EM for Metastatic Hormone-Refractory Prostate Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30944
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-30986, EORTC-GU-30986, NCT00014274
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
Phase II/III Comparison of VBL/Single-Dose DHAD vs VBL/5-Day DHAD for Metastatic Breast Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-MBDT-8085
High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: IIL-HD0801, EudracT Number 2008-002684-14, NCT00784537
Phase III Randomized Study of VBL vs VBL/EM for Metastatic Hormone-Refractory Prostate Cancer (Summary Last Modified 06/96)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HOG-GU93-1, NCI-V94-0424
Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CDR0000063579, FRE-IT94, FRE-FNCLCC-IT94, NCI-F94-0019, NCT00002566
Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9410, U10CA021661, CDR0000063640, NCT01134861
Phase III Comparison of 5-Day Continuous Infusions of DAVA vs VBL vs VCR for Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8008
Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 10 to 70
Sponsor: NCI, Other
Protocol IDs: ID95-196, P30CA016672, MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, CDR0000065188, NCT00002882
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-55954, MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209
Combination Chemotherapy in Treating Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000066808, E-1897, NCT00003701
Start Over